Involuntary mouthing movements indistinguishable from neuroleptic-induced tardive dyskinesia followed stroke in a woman whose computed tomographic (CT) scan showed bilateral thalamo-capsular infarction.

What You Can’t See Can Hurt You! Summer is here, the weather is warm and thoughts turn to sandy beaches and sunbathing as well as outdoor sports. While we may think to protect our skin from sunlight, we tend to forget about the eye. Both visible and invisible or ultraviolet (UV) portions of sunlight can damage the eye, lids and surrounding skin. The nature of the injury varies with the amount a...

The aim of this case report is to highlight that risperidone may cause and ameliorate tardive dyskinesia. A 16 year old white women with a 12 month history of schizophrenia, developed buccolingual masticatory tardive dyskinesia after receiving risperidone 6 mg. She had received small dosages of typical antipsychotics before and during receiving risperidone for short periods. Recommencement of r...

Efficacy of low dose levodopa in treatment of TD has been studied on 30 male inpatients with predefined selection criteria. The preliminary results are encouraging but long term double blind studies in larger samples are needed.

Two experiments tested the roles of hidden toys and motor history in the AB task with l&monthold infants. In Experiment 1 (N = 24), infants were tested in lid and toy versions of the task, each comprised of A and B trials. No toys were ever hidden in the lid condition. On all A trials, an experimenter directed infants’ attention to one of two lids (the A lid) and allowed infants to reach follow...

L-dopa is the most effective, currently available treatment for Parkinson's disease (PD), but it leads to the development of involuntary movements known as L-dopa-induced dyskinesia (LID) in the majority of patients after long-term use. Both gene and cell therapy approaches are the subject of multiple ongoing studies as potential ways of relieving symptoms of PD without the complication of dysk...

Abstract Aim: Dyskinesia is a hyperkinetic abnormal involuntary movement (AIM), like chorea, dystonia, athetosis, and ballism. AIM can occur in Levodopa-induced dyskinesia (LID) Parkinson's disease (PD), tardive (TD) schizophrenia, paroxysmal dyskinesias (PxDs). This review describes the effects of physical activity exercise adaptation (e.g., rehabilitation) most varied forms an attempt to prov...

Graft-induced dyskinesia (GID) is a serious complication induced by dopamine (DA) cell transplantation in parkinsonian patients. We have recently shown that DA D2 receptor blockade produces sticking blockade of dyskinesia induced by amphetamine in grafted 6OHDA-lesioned rats, a model of GID. This study was designed to investigate whether blockade of DA D1 receptors could produce similar outcome...